Marmara University Faculty of Health Sciences, Department of Physical Therapy and Rehabilitation, Istanbul, Turkey.
School of Physical and Occupational Therapy, McGill University, Faculty of Medicine and Health Sciences, Montreal, Quebec, Canada; Center for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
Prim Care Diabetes. 2022 Feb;16(1):49-56. doi: 10.1016/j.pcd.2021.12.005. Epub 2021 Dec 17.
The purpose of this study was to estimate, for people with type 2 diabetes (T2D), the extent to which glycemic control was affected by a 12-week program using mobile app and wearable smartwatch in comparison to supervised exercise training.
This study was a stratified, randomized, assessor-blind, controlled, pragmatic trial with three parallel groups which were supervised, mobile app and wearable smartwatch. Individually tailored exercise regimens delivered through a supervisor, mobile app and wearable smartwatch. Programs consisted of aerobic, resistance exercises, calisthenic, flexibility, balance, and coordination exercises. Primary outcome was change in glycemic control (HbA1c); secondary outcome was Six Minute Walk Test; and explanatory outcomes were exercise behaviour, muscle function, and physical capacity. The groups were contrasted for change in HbA1c and absolute reduction of ≥0.5% (Minimal Important Change). Linear and logistic regressions were used to compare the groups and generalized estimated equations were used to analyze the explanatory outcomes.
In total, 90 people were randomized, 6 were lost over 12 weeks, leaving 84 with outcome data. The difference in HbA1c did not differ between the supervised and the technology groups combined and between the mobile app and smartwatch group. Proportions of people achieving a clinically meaningful difference on HbA1c between the supervised and technology groups were similar (46% vs 43%) and the associated OR was 0.87 (95%CI:0.34-2.28). Within the two technology groups, proportions of people achieving a clinically meaningful difference in HbA1c were 48% in the mobile app and 38% in the smartwatch groups and the associated OR was 0.65 (95%CI:0.21-2.03). The groups did not differ on secondary and explanatory outcomes.
The results of our trial provide evidence that all outcomes have improved in all groups regardless of the exercise delivery method. Considering the supervised programs are not available for everybody, technological options are crucial to implement to help individuals self-manage most aspects of their diabetes.
本研究旨在评估使用移动应用程序和可穿戴智能手表进行 12 周计划对 2 型糖尿病(T2D)患者血糖控制的影响程度,与监督运动训练相比。
这是一项分层、随机、评估者盲、对照、实用的试验,有三个平行组,分别是监督组、移动应用程序组和可穿戴智能手表组。通过主管、移动应用程序和可穿戴智能手表提供个性化定制的运动方案。方案包括有氧运动、阻力训练、体操、柔韧性、平衡和协调训练。主要结局是血糖控制(HbA1c)的变化;次要结局是六分钟步行试验;解释性结局是运动行为、肌肉功能和身体能力。比较各组在 HbA1c 变化和绝对降低≥0.5%(最小重要变化)方面的差异。线性和逻辑回归用于比较组,广义估计方程用于分析解释性结局。
共有 90 人被随机分组,12 周内有 6 人失访,84 人有结局数据。监督组和技术组联合的 HbA1c 差异以及移动应用程序组和智能手表组之间的差异没有统计学意义。在监督组和技术组之间,HbA1c 达到临床有意义差异的人数比例相似(46%比 43%),相关 OR 为 0.87(95%CI:0.34-2.28)。在两个技术组内,HbA1c 达到临床有意义差异的人数比例分别为移动应用程序组 48%和智能手表组 38%,相关 OR 为 0.65(95%CI:0.21-2.03)。两组在次要和解释性结局上没有差异。
我们的试验结果提供了证据,表明所有组的所有结果都有所改善,无论运动传递方法如何。考虑到监督方案并非对所有人都可用,技术选择对于实施至关重要,以帮助个人自我管理他们糖尿病的大多数方面。